BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12650766)

  • 1. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
    Estein SM; Cassataro J; Vizcaíno N; Zygmunt MS; Cloeckaert A; Bowden RA
    Microbes Infect; 2003 Feb; 5(2):85-93. PubMed ID: 12650766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.
    Estein SM; Cheves PC; Fiorentino MA; Cassataro J; Paolicchi FA; Bowden RA
    Vet Microbiol; 2004 Sep; 102(3-4):203-13. PubMed ID: 15327795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.
    Cassataro J; Velikovsky CA; Bruno L; Estein SM; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Clin Vaccine Immunol; 2007 Jul; 14(7):869-74. PubMed ID: 17428946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2015 Oct; 33(42):5532-5538. PubMed ID: 26384448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species.
    Vizcaíno N; Kittelberger R; Cloeckaert A; Marín CM; Fernández-Lago L
    Infect Immun; 2001 Nov; 69(11):7020-8. PubMed ID: 11598077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies.
    Bowden RA; Estein SM; Zygmunt MS; Dubray G; Cloeckaert A
    Microbes Infect; 2000 Apr; 2(5):481-8. PubMed ID: 10865193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an immuno-dominant antigen in Brucella ovis and evaluation of its use in an enzyme-linked immunosorbent assay.
    Kittelberger R; Diack DS; Vizcaíno N; Zygmunt MS; Cloeckaert A
    Vet Microbiol; 1998 Jan; 59(2-3):213-27. PubMed ID: 9549861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
    Bowden RA; Cloeckaert A; Zygmunt MS; Dubray G
    J Med Microbiol; 1998 Jan; 47(1):39-48. PubMed ID: 9449948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ; Marín CM; Barberán M; de Miguel MJ; Laroucau K; Jacques I; Blasco JM
    Vaccine; 2009 Jan; 27(2):187-91. PubMed ID: 19007836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines.
    Jiménez de Bagüés MP; Elzer PH; Blasco JM; Marín CM; Gamazo C; Winter AJ
    Infect Immun; 1994 Feb; 62(2):632-8. PubMed ID: 8300219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
    Cassataro J; Velikovsky CA; de la Barrera S; Estein SM; Bruno L; Bowden R; Pasquevich KA; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Oct; 73(10):6537-46. PubMed ID: 16177328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams.
    Blasco JM; Gamazo C; Winter AJ; Jiménez de Bagüés MP; Marín C; Barberán M; Moriyón I; Alonso-Urmeneta B; Díaz R
    Vet Immunol Immunopathol; 1993 Aug; 37(3-4):257-70. PubMed ID: 8236802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis.
    Bowden RA; Cloeckaert A; Zygmunt MS; Dubray G
    J Med Microbiol; 1995 Nov; 43(5):344-7. PubMed ID: 7562998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization of mice with Omp31-loaded
    Abkar M; Fasihi-Ramandi M; Kooshki H; Sahebghadam Lotfi A
    Int J Nanomedicine; 2017; 12():8769-8778. PubMed ID: 29263667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae.
    Cassataro J; Pasquevich K; Bruno L; Wallach JC; Fossati CA; Baldi PC
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):111-4. PubMed ID: 14715555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis.
    Edmonds MD; Cloeckaert A; Elzer PH
    Vet Microbiol; 2002 Sep; 88(3):205-21. PubMed ID: 12151196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.